Matthew McClintock 7/2/25 Matthew McClintock 7/2/25

Nike: Pigs At The Trough Often Get Slaughtered

Management called the bottom after 4Q25; we test whether Nike's turnaround is really underway.

Matthew McClintock 6/16/25 Matthew McClintock 6/16/25

RH: Time For A Resto In Hype

Takeaways from RH's 1Q25 results, focused on its international expansion; our view on the stock stays negative.

Matthew McClintock 6/8/25 Matthew McClintock 6/8/25

What to watch as RH reports 1Q25, with sentiment turning negative and heavy discounting looking permanent.

Matthew McClintock 2/10/25 Matthew McClintock 2/10/25

Distribution, not just innovation, is Nike's biggest problem today, and it may be structural rather than quickly fixable.

Matthew McClintock 12/18/24 Matthew McClintock 12/18/24

After Under Armour's investor day, a data-driven review of its distribution cleanup ahead of new product launches.

Matthew McClintock 11/12/24 Matthew McClintock 11/12/24

Why Foot Locker is where the athletic footwear share shift shows up first.

Matthew McClintock 10/23/24 Matthew McClintock 10/23/24

RH's Aspen Guesthouse is delayed again after a contested historical commission vote; a city council hearing follows.

Matthew McClintock 9/24/24 Matthew McClintock 9/24/24

Audited UK filings back our doubts about RH's European expansion against the $50 to $250 million first-year sales forecast.

Matthew McClintock 8/14/24 Matthew McClintock 8/14/24

Moving past the Donahoe blame game to map out what a realistic Nike recovery path could look like.

Matthew McClintock 6/25/24 Matthew McClintock 6/25/24

Why a valuation-only short thesis on Costco rarely works.

Matthew McClintock 4/21/24 Matthew McClintock 4/21/24

A great business and management team, but at 55x forward earnings the stock has priced in too much.

Matthew McClintock 4/14/24 Matthew McClintock 4/14/24

Why the Donahoe hire never made sense, and his attempt to blame Nike's innovation slump on remote work.